Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02036190 · ClinicalTrials.gov registry record
Ancillary T Cell Based Studies in SPIROMICS
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 175
- Enrollment target
NCT02036190 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 175 participants.
The verdict
NCT02036190 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 175 participants
- Enrollment target
Study Summary
The long-term objectives of this ancillary application are to characterize a subpopulation of smokers with auto-reactive T cell response, to validate immunodiagnostic assays that could detect emphysema, and to find molecular signatures for pathogenic T cell development in a well-characterized cohort participating in SPIROMICS (UCSF center).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2012-02 |
| Est. Completion | 2016-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02036190
The ClinicalTrials.gov registry entry for NCT02036190 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 175 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02036190 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02036190 about?
NCT02036190 is a clinical study titled "Ancillary T Cell Based Studies in SPIROMICS". The long-term objectives of this ancillary application are to characterize a subpopulation of smokers with auto-reactive T cell response, to validate immunodiagnostic assays that could detect emphysema, and to find molecular signatures for pathogenic T cell development in a well-characterized cohort...
What is the current status of trial NCT02036190?
This trial is currently completed. The enrollment target is 175 participants. The study started on 2012-02. Estimated completion is 2016-01.
Who is sponsoring clinical trial NCT02036190?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.